029HO19865 ESKER-PP

Print/PDF
Registration Name TTM ESKER-PP-ET
Registration Number HO840003210987610
Primary NAAB Code 029HO19865
Secondary Code(s) 629HO19865
Status Inactive
Controller Name ABS Global (29)
Date of Birth 8/3/2020
aAa -
DMS -
GFI 11.6%
Genetic Codes * PP TY TV TR TL TD TC TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-A
Sire BOMAZ MONUMENT-P-ET
MGS S-S-I PR RENEGADE-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AB
INDEXES
NM$ 639, 90% R CM$ 672
NM Percentile 64% FM$ 558
GTPI 2993 GM$ 593
PRODUCTION TRAITS
1631 Dtrs 124 herds 78 % US 99% R
Milk 1177 Fat, % 83 , +0.12%
SCS 3.04, 98% R Protein, % 60 , +0.08%
Feed Saved -67 , 55% R Milking Speed 7.83 , 73% R
Health & Fertility
Productive Life 1.2      92% R Mastitis 0.4      85% R
Heifer Livability -0.9       69% R Metritis 1.8      84% R
Livability 0.5      80% R D. Abom 0.2      91% R
DPR -1.9      95% R Ketosis -0.4      84% R
FSC -6.8      95% R R. Placenta -0.1      85% R
HCR -1.7      90% R Milk Fever 0.2      72% R
CCR -1.7      95% R
SCR -        -
DIA 0.1      52% R
RSP -1.9      62% R
Calving Traits
Sire CE 1.2      97% R 1740 Obs
Daughter CE 1.7      90% R 624 Obs, 533 Dtrs
Sire SB 3.4      90% R 1106 Obs
Daughter SB 3.4      87% R 367 Obs, Dtrs
Gestation Length 0.8      99% R 151 Obs, 3307 Dtrs
Early First Calving -2.1      91% R 52 Obs, 347 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
109 Dtrs 14 herds 92% R
PTA Type -0.86 UDC -1.17
HCC 0.13 BWC -0.55
FLC -0.01
Linear Traits
Stature -0.79
Short
Strength -0.53
Weak
Body Depth -0.65
Shallow
Dairy Form -0.34
Closed
Rump Angle 1.43
Sloped
Thurl Width -0.55
Sloped
Rear Legs-Side View -0.55
Narrow
Rear Legs-Rear View -0.10
H.-in
Foot Angle -0.60
Low
Feet & Legs Score -0.14
Low
F.U. Attachment 0.82
Curved
Rear Udder Height -1.28
Low
Rear Udder Width -0.93
Narrow
Udder Cleft -0.66
Weak
Udder Depth -0.10
H.-in
Front Teat Placement -1.00
Wide
Rear Teat Placement -0.64
Wide
Teat Length 1.36
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO